Cambridge Investment Research Advisors’s VeriSign VRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Sell
5,372
-75
-1% -$20.8K ﹤0.01% 2018
2026
Q1
$1.35M Sell
5,447
-210
-4% -$50K ﹤0.01% 1916
2025
Q4
$1.37M Sell
5,657
-282
-5% -$70.8K ﹤0.01% 1852
2025
Q3
$1.66M Buy
5,939
+95
+2% +$26.5K ﹤0.01% 1642
2025
Q2
$1.69M Sell
5,844
-256
-4% -$69.4K 0.01% 1555
2025
Q1
$1.55M Buy
6,100
+1,510
+33% +$343K 0.01% 1524
2024
Q4
$950K Buy
4,590
+128
+3% +$24.1K ﹤0.01% 1918
2024
Q3
$848K Buy
4,462
+884
+25% +$159K ﹤0.01% 1973
2024
Q2
$636K Buy
3,578
+755
+27% +$135K ﹤0.01% 2103
2024
Q1
$535K Sell
2,823
-762
-21% -$150K ﹤0.01% 2220
2023
Q4
$738K Buy
+3,585
New +$746K ﹤0.01% 1862
2021
Q1
Sell
-1,239
Closed -$268K 2997
2020
Q4
$268K Buy
+1,239
New +$254K ﹤0.01% 2241
2019
Q3
Sell
-2,081
Closed -$435K 2415
2019
Q2
$435K Buy
2,081
+232
+13% +$45.6K ﹤0.01% 1521
2019
Q1
$336K Buy
1,849
+175
+10% +$30K ﹤0.01% 1742
2018
Q4
$248K Sell
1,674
-1,761
-51% -$264K ﹤0.01% 1788
2018
Q3
$550K Buy
+3,435
New +$526K 0.01% 1384
2015
Q1
Sell
-8,661
Closed -$494K 1455
2014
Q4
$494K Sell
8,661
-998
-10% -$57.6K 0.02% 787
2014
Q3
$532K Buy
9,659
+3,060
+46% +$165K 0.02% 796
2014
Q2
$322K Buy
6,599
+2,755
+72% +$137K 0.01% 984
2014
Q1
$207K Buy
+3,844
New +$218K 0.01% 1139

Other funds holding VRSN

Cambridge Investment Research Advisors's VRSN Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its VeriSign (VRSN) stake by 1.4% in Q2 2026, selling an estimated $20.8K and leaving 5,372 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2018.

Cambridge Investment Research Advisors first reported a position in VRSN in Q1 2014 and has held it in 20 quarters since. The position peaked at $1.69M in Q2 2025. 873 funds tracked by Wall St. Rank hold VRSN as of Q2 2026.

  • Cambridge Investment Research Advisors held 5,372 shares of VeriSign worth $1.35M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 75 VeriSign shares in Q2 2026, an estimated $20.8K.
  • VeriSign made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2018 holding.
  • Cambridge Investment Research Advisors first reported a position in VeriSign in Q1 2014 and has held it in 20 quarters since.
  • Cambridge Investment Research Advisors's VeriSign position peaked at $1.69M in Q2 2025.
  • 873 funds tracked by Wall St. Rank held VeriSign as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.